Sutro Biopharma STRO Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$38.48M+49.3% | -$46.76M+35.4% | -$56.86M-16.5% | -$11.5M+76.1% | -$75.97M-30.5% | ||
| $1.28M-32.7% | $1.62M-13.1% | $1.9M+5.6% | $1.9M+6.1% | $1.9M+7.9% | ||
| $1.56M-71.8% | $1.66M-72.0% | $1.55M-76.3% | $5.26M-14.5% | $5.54M-8.7% | ||
| —— | $423.5K— | $423.5K— | $423.5K— | $423.5K— | ||
| $8.51M+72.0% | $0— | -$4.08M-1,282% | -$5.56M+77.2% | $4.95M+204% | ||
| -$2.55M-35.4% | —— | —— | -$3.85M-176% | -$1.88M+0.8% | ||
| -$9.29M-587% | $1.39M+613% | $1.48M— | $210K— | -$1.35M+82.2% | ||
| $1M+9,218% | -$4.98M-172% | -$7.95M-412% | -$6.41M— | -$11K-100% | ||
| -$109K+35.1% | -$111K+28.8% | -$157K+12.8% | -$135K+44.0% | -$168K+11.1% | ||
| -$1.96M+59.0% | -$145K— | -$6.14M— | -$58.67M-307% | -$4.78M+34.0% | ||
| -$2.04M-16.2% | -$1.99M-16.2% | -$1.93M-16.2% | -$1.8M-16.8% | -$1.76M-16.9% | ||
| -$42.26M+37.7% | -$26.44M+63.2% | -$38.19M+40.8% | -$44.72M— | -$67.88M-4.9% | ||
| $0-100% | —— | $47K-91.5% | —— | $27K-87.7% | ||
| -$45.26M-178% | $18.7M-78.6% | $39.99M-72.9% | $2.58M+103% | -$16.26M-125% | ||
| —— | —— | —— | —— | —— | ||
| —— | $0— | $0— | $0— | $0-100% | ||
| $28K— | $0— | $0— | $0-100% | $0-100% | ||
| $160K-11.1% | $67K+179% | $25K-66.2% | $60K+62.2% | $180K-51.9% | ||
| $103.08M+156,074% | —— | $102K-90.0% | —— | $66K+102% | ||
| $15.55M+118% | -$7.8M-150% | $0-100% | -$42.2M-265% | -$84.08M-1,968% | ||
| -$15K-314% | $64K-97.3% | $0-100% | $4K-100.0% | $7K-30.0% | ||
| $445K-60.1% | $531K-65.5% | $755K-72.0% | $1.03M-63.5% | $1.12M-58.0% | ||
| —— | $423.5K— | $423.5K— | $423.5K— | $423.5K— | ||
| $8.4M+51.3% | —— | —— | $1.56M+134% | $5.55M+826% | ||
| -$9.29M-587% | $1.39M+613% | $1.48M— | $210K— | -$1.35M+82.2% | ||
| -$2.04M-16.2% | -$1.99M-16.2% | -$1.93M-16.2% | -$1.8M-16.8% | -$1.76M-16.9% | ||
| $1M+9,218% | -$4.98M-172% | -$7.95M-412% | -$6.41M— | -$11K-100% | ||
| $9.47M+1.3% | $9.55M+9.9% | $9.7M+22.8% | $9.7M+32.9% | $9.34M+30.1% | ||
| $1.2M-14.4% | $1.55M+14.7% | $1.5M+14.5% | $1.44M+14.5% | $1.4M+14.4% | ||
| -$109K+35.1% | -$111K+28.8% | -$157K+12.8% | -$135K+44.0% | -$168K+11.1% | ||
| $11K-99.1% | $184K-82.8% | $251K-69.7% | $86K-88.6% | $1.17M+163% | ||
| $103.13M— | $0-100% | $0-100% | $0-100% | $0-100% | ||
| $81K-67.1% | —— | $126K-86.6% | —— | $246K-73.0% | ||
| $0-100% | —— | $47K-91.5% | —— | $27K-87.7% | ||
| $435K— | —— | —— | —— | $0-100% | ||
| $911K-22.5% | $759K-31.2% | $646K-49.1% | $832K-52.7% | $1.18M-45.6% | ||
| -$1.96M+59.0% | -$145K— | -$6.14M— | -$58.67M-307% | -$4.78M+34.0% | ||
| -$2.04M-16.2% | -$1.99M-16.2% | -$1.93M-16.2% | -$1.8M-16.8% | -$1.76M-16.9% | ||
| $468K— | —— | —— | —— | $0— | ||
| -$15K-314% | $64K-97.3% | $0-100% | $4K-100.0% | $7K-30.0% | ||
| -$42.26M+37.8% | -$26.38M+63.2% | -$38.24M+41.2% | -$44.72M— | -$67.91M-4.5% | ||
| -$42.26M+37.8% | -$26.38M+63.2% | -$38.24M+41.2% | -$44.72M— | -$67.91M-4.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Sutro Biopharma generate?
- Sutro Biopharma (STRO) generated -$151.6M in operating cash flow over the trailing twelve months.
- What is Sutro Biopharma's free cash flow?
- After $627.0K of capital expenditures, Sutro Biopharma's free cash flow was -$151.6M over the trailing twelve months, up 25.9% year over year.
- Where does Sutro Biopharma's cash flow data come from?
- Every line is extracted from Sutro Biopharma's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
